larvicides market Trends over recent years reflect increasing awareness of, and concern about vector-borne diseases. Larvicides are chemicals or biological substances applied on the breeding sites of mosquito larvae to help curb their birth and control diseases like malaria, dengue, and Zika virus. A remarkable feature in the larvicides market is growing demand for eco-friendly and sustainable products. Therefore, consumers and regulatory bodies are asking for larvicides that do not affect the environment very much or other organisms than its target. Another noteworthy development is increased research and development activities to put out new larvicidal formulations. Some of the market participants in larvicides are also investing on innovative formulations that will enable them to control mosquitoes’ invention better without necessarily hurting human or other non-target forms. This trend is necessary to obtain more effective and specific solutions for combating the increasing threat of vector-borne diseases in different parts of our planet. The larvicides market is witnessing a surge in demand as the government initiatives and programs with mosquito control have increased. governments in different regions are becoming more aware of the need for proactive actions to control mosquito populations and prevent disease outbreaks. This has resulted in the application of larvicides programs both urban and rural locations that have helped to grow this market as well. Moreover, the larvicides industry is moving toward integrated mosquito management strategies. Integrated mosquito management is characterized by a coordinated use of various control measures such as larvicides, adulticides and environmental management practices. This holistic point of view is becoming more popular since it tackled both larvae and adult mosquitoes at different points in the life cycle. The prevalence of mosquito-borne diseases in some regions is also a contributing factor to the larvicides market. With the increasing incidents of diseases like malaria, dengue and chikungunya the demand for efficient larvicidal products is on increased. In tropical and subtropical regions, where mosquitoes propagate easily throughout the year, this trend is particularly marked as a threat to public health. In terms of product categories, bio-based larvicides are becoming popular within the market. Bio-based larvicides are made from natural sources and have been viewed as more eco-friendly than conventional chemical larvicides.
Larvicides Market Size was valued at USD 0.94 Billion in 2023. The larvicides market industry is projected to grow from USD 0.98888 Billion in 2024 to USD 1.42 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.63 % during the forecast period (2024 - 2032). Escalating incidences of vector-borne diseases, stringent environmental regulations promoting sustainable pest control practices, the rising need for effective agricultural productivity and crop protection measures, and continuous technological advancements leading to improved larvicide formulations are the key market drivers fostering robust growth in the larvicides market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The key factor driving the market CAGR of larvicides is an upsurge in the prevalence of insect-borne diseases, particularly in developing and least-developed countries. Most countries, including South America, have become devastated by mosquito-borne diseases. Malaria claimed the lives of 126 Venezuelans in 2019. Larvicide can control deadly infections such as malaria, chikungunya, and dengue. For example, disease outbreaks such as the Zika virus have made the European region more vulnerable to mosquito population spread. Malaria affects Sub-Saharan Africa, the Middle East, Latin America, Asia, and Europe. As a result, rising dengue and malaria incidences present an opportunity for the larvicides market in the target region. Furthermore, government spending in the developing sector, as well as the participation of international corporations, fuel the larvicides industry.
Factors such as the growing prevalence of vector-borne diseases, climate changes, increasing pest population, and ecological sustainability drive the larvicides market revenue growth. According to the WHO, 40% of the population in developing nations is in danger of catastrophic diseases like malaria, which is caused by parasites spread by female anopheles’ mosquitoes. For example, there were 219 million malaria cases in 87 countries in 2018, and overall malaria control funding was anticipated to be USD 3.1 billion. A growing number of disease outbreaks, vector-borne epidemics, and increasing pest attacks are some of the key factors propelling the larvicides market. Due to climate change, which concerns public health caused by urban pests, Asia-Pacific owns the largest proportion of the larvicides market.
Based on control type, the larvicides market segmentation includes biocontrol agents, chemical agents, and insect growth regulators. The chemical agent segment dominated the market, accounting for 42% of market revenue (0.4 billion). Chemical larvicides can efficiently suppress mosquito larvae. They are specifically designed to locate and kill mosquito larvae at various stages of development. Chemical chemicals can successfully and quickly destroy mosquito larvae, reducing mosquito populations and the risk of mosquito-borne diseases. They offer several application methods, including spray, granular, and liquid formulations. Chemical larvicides are frequently effective in controlling mosquito larvae. They take immediate impact after application, inhibiting larval growth and preventing adult mosquitos from developing. Chemical larvicides are typically an effective method of mosquito control. Their use can lower mosquito populations, reducing the need for regular and costly adult mosquito control treatments.
Figure 1: Larvicides Market, by Control Type, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The biocontrol agent segment is expected to grow at the fastest CAGR in the larvicides industry in the coming years. With growing environmental concerns and the need to reduce the ecological impact of chemical pesticides, there is a rising demand for biocontrol agents in larvicides. Biocontrol agents, such as certain bacteria, fungi, nematodes, and other beneficial organisms, offer an eco-friendly alternative for controlling larvae without harming non-target species and the environment. Governments and regulatory bodies in many countries impose strict regulations on chemical pesticides due to their potential negative effects on human health and the environment. As a result, there is a shift towards adopting biocontrol agents as safer and more sustainable options for larval control, further driving the growth of this segment.
Based on form, the larvicides market segmentation includes solid and liquid. The liquid segment dominated the market, accounting for 66% of revenue. Liquid larvicides offer convenient application methods, allowing for uniform coverage of the target areas. They can be easily sprayed, poured, or applied through irrigation systems, ensuring the effective distribution of the larvicide across different breeding sites. Liquid larvicides are versatile and can be formulated to suit various application methods, including aerial, ground, and water-based applications. Moreover, they are compatible with different equipment and delivery systems, providing flexibility for use in diverse agricultural and non-agricultural settings.
Based on the target, the larvicides market segmentation includes mosquitoes, flies, and others. The flies category generated the most income (30%). Flies like house flies and stable flies are known vectors for various diseases, including cholera, dysentery, and foodborne illnesses. Controlling fly populations with larvicides is crucial for preventing disease transmission, particularly in urban and densely populated areas where flies can quickly spread pathogens. The livestock and poultry industries face significant economic losses due to fly infestations. Flies cause animal stress and discomfort, reducing feed efficiency and growth rates. The demand for larvicides targeting flies is driven by the need to improve animal health and productivity in these sectors.
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia Pacific larvicides market accounted for USD 0.41 billion in 2022 and will likely exhibit a significant CAGR growth in the study period. One of the primary factors driving the regional market is the rising awareness of vector-borne diseases and their impact on public health. Countries in the region, particularly those with tropical and subtropical climates, are prone to disease outbreaks carried by mosquitoes and other vectors. As a result, there is a growing demand for larvicides to control mosquito larvae and reduce the transmission of diseases such as malaria, dengue fever, and chikungunya.
Further, the major countries studied in the market report are The US, German, Canada, the UK, France, Spain, Italy, Japan, India, China, South Korea, Australia, and Brazil.
Figure 2: LARVICIDES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe larvicides market accounts for the second-largest market share. The region has witnessed outbreaks of vector-borne diseases in recent years, including West Nile virus and Lyme disease, transmitted by mosquitoes and ticks. Governments and health authorities increasingly emphasize larvicide-based vector control programs to curb disease transmission and protect public health. Environmental consciousness and stringent regulations on pesticide use are also driving the demand for larvicides in Europe. The region strongly focuses on sustainability and ecosystem protection, leading to the adoption of larvicides as a more targeted and environmentally friendly pest control solution. Further, the German larvicides market held the largest market share, and the UK larvicides market was the fastest-growing market in the European region.
The North American Larvicides Market is expected to grow at the fastest CAGR from 2023 to 2032. Public health concerns related to vector-borne diseases, such as West Nile virus, Zika virus, and Eastern equine encephalitis, are major drivers of larvicide demand in the region. Government agencies and municipalities actively implement larvicide-based mosquito control programs to lower the risk of disease transmission and protect the health of residents. Moreover, the US larvicides market held the largest market share, and the Canadian larvicides market was the fastest-growing market in the North American region.
Leading market players make substantial R&D investments to innovate and expand their product portfolios. These investments aim to develop more effective and efficient larvicide formulations, addressing various insect pests and disease vectors. Key market developments include new product launches and the introduction of innovative larvicide solutions with improved efficacy and safety profiles. Additionally, major companies in the larvicides industry are engaging in contractual agreements with regional distributors and partners to expand their market reach and offer localized pest control solutions tailored to specific regions.
Mergers and acquisitions are also prevalent in the larvicides industry, as major players seek to augment their market share and consolidate their position. These strategic moves allow companies to access new technologies and expertise, bolstering their capabilities to cater to diverse pest management needs. In recent years, the larvicides industry has experienced significant growth, driven by increasing awareness of vector-borne diseases and the need for sustainable pest control solutions. The market has offered substantial advantages in public health by mitigating disease transmission through targeted vector control. Major players in the larvicides market, including BASF SE (Germany), Bayer AG (Germany), Sumitomo Chemical Co. Ltd (Japan), Syngenta (Switzerland), Certis USA LLC (US), ADAMA Ltd (Israel), Nufarm Limited (Australia), Central Garden & Pet Company (US), Gowan Company (US), Russell IPM Ltd (UK), Arysta LifeScience Corporation (US), and Eli Lily & Company (US), are striving to meet the growing market demand by investing in research and development operations.
Nufarm Limited is a prominent agricultural chemical company headquartered in Melbourne, Australia. Nufarm specializes in developing, manufacturing, and distributing various innovative crop protection products, including herbicides, insecticides, fungicides, and plant growth regulators. These products cater to diverse crops such as cereals, oilseeds, fruits, vegetables, pastures, ornamental plants, and turf. Operating in various countries worldwide, Nufarm has established a significant international presence, with manufacturing facilities and operations strategically located in key agricultural regions across Australia, North and South America, Europe, and the Asia-Pacific.
Russell IPM Ltd is a renowned British company that provides innovative pest control solutions for various industries, including agriculture, public health, and urban pest management. With over three decades of experience, the company has established itself as a leading player in developing and manufacturing environmentally friendly and sustainable pest management products. Russell IPM's core focus lies in producing effective larvicides, insecticides, and attractants that target a wide range of pest species. In 2020, Russell IPM introduced a groundbreaking larvicide formulation showcased remarkable results in controlling mosquito larvae in multiple field trials. The new larvicide formulation combines highly potent active ingredients with eco-friendly carriers, allowing for targeted and efficient application in mosquito breeding sites
Recent News :
Safeway Pest Control Limited, a privately owned Bangladeshi corporation, introduced three BTI (Bacillus Thuringiensis Israelensis) insecticides in September 2023 for the management of mosquito larvicides, claiming it to be the most environmentally friendly and efficient method for preventing dengue outbreaks. Safeway Pest Control, a partner of the United States-based company Valent BioScience, characterized these three insecticides as exceptionally effective living organisms for killing mosquito larvae at a hotel event. In order to combat the dengue outbreak in the country, Safeway Pest Control Limited will collaborate with the two city corporations regarding the application of these BTI insecticides.
May 2023 marked the initial approval by the Pest Management Regulatory Agency (PMRA) of the utilization of drones as an application method for three Public Health products manufactured by Valent BioSciences LLC. The larvicides VectoBac 200G, VectoBac 1200L, and VectoLex CG, which are utilized for the management of black flies and mosquitoes, are the initial products to receive approval for drone application in Canada. The PMRA has previously prohibited the use of Remote Piloted Aircraft Systems (RPAS), which are presently employed in numerous regions of the United States for the purposes of larvicide application and insect population monitoring. Progress in application technology, such as the implementation of RPAS, offers labor management and operational cost savings to public health professionals
Larvicides Industry Developments
May 2020: ADAMA Ltd purchased the remaining 51% of Alfa Agricultural Supplies SA, a major Greek provider of crop protection and other agricultural products.
July 2019: ADAMA US has introduced a new service to its consumers. ADAMA Eagle Eye powered by Agremo provides advanced analysis of aerial data and imagery to assist farmers in more efficiently protecting crops through user-friendly maps, statistics, and additional practical tools.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)